NNNN CIK: 1982708

Anbio Biotechnology

  • Germany
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
4.45
FY23:
0.90
FY24:
2.08
FY25:
−6.74
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−1.53
FY23:
1.73
FY24:
0.34
FY25:
−4.20
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−0.04
FY24:
−0.34
FY25:
6.95
(positive)
Change from FY21 to FY25
millions USD
FY21:
4.18
FY22:
–
FY23:
0.90
FY24:
2.08
FY25:
−6.74

All amounts in millions USD FY21: figures supplemented from Twelve Data because the SEC filings do not reach back this far. Data sources:SEC EDGARTwelve Data